Editorial: Pathogenic potassium channel variants in neurological disorders: from functional analysis to personalized pharmacological approaches.
作者信息
Servettini Ilenio, Guglielmi Luca, Sforna Luigi, Catacuzzeno Luigi
机构信息
Department of Medicine and Health Science "V. Tiberio, " University of Molise, Campobasso, Italy.
MRC Laboratory of Molecular Biology (LMB), Cambridge, United Kingdom.
出版信息
Front Cell Neurosci. 2025 Jul 30;19:1614320. doi: 10.3389/fncel.2025.1614320. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Pathogenic potassium channel variants in neurological disorders: from functional analysis to personalized pharmacological approaches.社论：神经疾病中的致病性钾通道变体：从功能分析到个性化药理学方法
Front Cell Neurosci. 2025 Jul 30;19:1614320. doi: 10.3389/fncel.2025.1614320. eCollection 2025.
2
BK channel activity in skin fibroblasts from patients with neurological disorder.神经系统疾病患者皮肤成纤维细胞中的BK通道活性
Channels (Austin). 2025 Dec;19(1):2542811. doi: 10.1080/19336950.2025.2542811. Epub 2025 Aug 10.
3
Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients.癫痫-运动障碍综合征的分子与临床谱：609例患者的横断面研究
Brain. 2025 Aug 14. doi: 10.1093/brain/awaf297.
8
Pathogenic variants associated with speech/cognitive delay and seizures affect genes with expression biases in excitatory neurons and microglia in developing human cortex.与言语/认知延迟和癫痫发作相关的致病变异会影响在发育中的人类皮质的兴奋性神经元和小胶质细胞中具有表达偏向性的基因。
bioRxiv. 2024 Jul 2:2024.07.01.601597. doi: 10.1101/2024.07.01.601597.
9
Comprehensive clinical and molecular characterization with long-term outcomes in 40 patients with congenital hyperinsulinism.40例先天性高胰岛素血症患者的综合临床与分子特征及长期预后
Endocrine. 2025 May 18. doi: 10.1007/s12020-025-04244-5.
10
The Use of AI for Phenotype-Genotype Mapping.人工智能在表型-基因型映射中的应用。
Methods Mol Biol. 2025;2952:369-410. doi: 10.1007/978-1-0716-4690-8_21.
本文引用的文献
1
De novo variants in KCNA3 cause developmental and epileptic encephalopathy.KCNA3基因的新生变异导致发育性和癫痫性脑病。
Ann Neurol. 2024 Feb;95(2):365-376. doi: 10.1002/ana.26826. Epub 2023 Dec 28.
2
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.一种新型 KCNC1 功能获得性变异导致发育性和癫痫性脑病：氟西汀的“精准医学”方法。
Epilepsia. 2023 Jul;64(7):e148-e155. doi: 10.1111/epi.17656. Epub 2023 Jun 2.
3
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties.KCNT2 相关疾病：表型、功能和药理学特性。
Ann Neurol. 2023 Aug;94(2):332-349. doi: 10.1002/ana.26662. Epub 2023 May 22.
4
Human de novo mutations underlie epilepsy and intellectual disability.人类新生突变是癫痫和智力障碍的基础。
J Neurophysiol. 2022 Jul 1;128(1):40-61. doi: 10.1152/jn.00509.2021. Epub 2022 May 18.
5
4-Aminopyridine is a promising treatment option for patients with gain-of-function -encephalopathy.4-氨基吡啶是治疗功能获得性脑病患者的一种有前途的治疗选择。
Sci Transl Med. 2021 Sep;13(609):eaaz4957. doi: 10.1126/scitranslmed.aaz4957. Epub 2021 Sep 1.
6
Potassium channels and autism spectrum disorder: An overview.钾通道与自闭症谱系障碍：概述。
Int J Dev Neurosci. 2021 Oct;81(6):479-491. doi: 10.1002/jdn.10123. Epub 2021 Jun 22.
7
Ion Channels Involvement in Neurodevelopmental Disorders.离子通道与神经发育障碍
Neuroscience. 2020 Aug 1;440:337-359. doi: 10.1016/j.neuroscience.2020.05.032. Epub 2020 May 28.
8
Genetic potassium channel-associated epilepsies: Clinical review of the K family.遗传性钾离子通道相关性癫痫：K 家族的临床综述。
Eur J Paediatr Neurol. 2020 Jan;24:105-116. doi: 10.1016/j.ejpn.2019.12.002. Epub 2019 Dec 14.
9
Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.扩展 KCNB1 变异在发育性和癫痫性脑病中的遗传和表型相关性：27 例新病例及文献综述。
Hum Mutat. 2020 Jan;41(1):69-80. doi: 10.1002/humu.23915. Epub 2019 Oct 4.
10
Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy.自闭症谱系障碍和癫痫患儿星形胶质细胞Kir4.1通道的功能获得性缺陷
Sci Rep. 2016 Sep 28;6:34325. doi: 10.1038/srep34325.
Zotero 插件